Timor-López Enrique, Tolosa Laia, Donato M Teresa
Experimental Hepatology Unit, Health Research Institute La Fe (IISLAFE), Torre A. Instituto Investigación Sanitaria La Fe Av Fernando Abril Martorell 106, 46026, Valencia, Spain.
Faculty of Medicine and Dentistry, Department of Biochemistry and Molecular Biology, University of Valencia, 46010, Valencia, Spain.
Arch Toxicol. 2025 Mar 11. doi: 10.1007/s00204-025-04016-0.
Drug-induced cholestasis is one of the major mechanisms implicated in drug-induced hepatotoxicity that poses a serious problem in terms of patient morbidity and mortality, healthcare system expenses and efficacy of newly developed drugs. Impaired bile acid homeostasis due to transporter alterations, hepatocellular injury or canalicular abnormalities is the most characteristic feature of cholestasis. Given the complexity of cholestasis and the different underlying mechanisms, new models and technologies that span a variety of biological processes are needed to accurately predict drugs' cholestatic potential. This review outlines the main triggering mechanisms of drug-induced cholestasis and summarizes the currently available in vitro systems and techniques that attempt to forecast and provide mechanistic details of cholestasis caused by drugs.
药物性胆汁淤积是药物性肝毒性的主要机制之一,在患者发病率和死亡率、医疗系统费用以及新开发药物的疗效方面构成严重问题。由于转运体改变、肝细胞损伤或胆小管异常导致胆汁酸稳态受损是胆汁淤积最典型的特征。鉴于胆汁淤积的复杂性和不同的潜在机制,需要跨越多种生物过程的新模型和技术来准确预测药物的胆汁淤积潜力。本综述概述了药物性胆汁淤积的主要触发机制,并总结了目前可用的体外系统和技术,这些系统和技术试图预测并提供药物引起胆汁淤积的机制细节。